Literature DB >> 25562147

Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease.

Yue Ying Feng1, Xiao Qin Xu, Chen Bo Ji, Chun Mei Shi, Xi Rong Guo, Jun Fen Fu.   

Abstract

BACKGROUND/AIM: Emerging evidence suggests that microRNA (miRNA) mediated gene regulation influences the maintenance of metabolic homeostasis, particularly the states of obesity and insulin resistance, thereby providing a potential link between miRNAs and nonalcoholic fatty liver disease (NAFLD).
METHODS: Sprague-Dawley rats fed a high-fat diet (HFD) were used to establish a rat model of NAFLD. The miRNA expression profile of liver tissues was evaluated using Illumina HiSeq deep sequencing. Selected miRNAs were then validated by real-time PCR at both 4- and 12-week time points. Furthermore, the expression levels of these miRNAs were assessed in HepG2 cells and human hepatocytes treated with free fatty acids (FFAs) and proinflammatory factors (tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6).
RESULTS: Our results showed that consumption of a HFD for 4 weeks caused simple steatosis, which progressed to steatohepatitis at 12 weeks. miRNA deep sequencing analysis identified 44 known up-regulated miRNAs (fold change >1.5) and 12 down-regulated miRNAs (fold change <0.5). Among the abnormally expressed miRNAs, miR-200a, miR-200b, miR-200c, miR-146a, miR-146b and miR-152 were up-regulated both in vitro and vivo. Interestingly, the expression levels of these six miRNAs were increased in HepG2 cells and human hepatocytes after treatment with FFAs and proinflammatory factors.
CONCLUSION: These findings suggest a critical role for miRNAs in the pathogenesis of NAFLD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25562147     DOI: 10.1159/000366394

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  36 in total

Review 1.  Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis.

Authors:  Johanna K DiStefano
Journal:  Cell Mol Life Sci       Date:  2020-06       Impact factor: 9.261

Review 2.  Lin28 and let-7: roles and regulation in liver diseases.

Authors:  Kelly McDaniel; Chad Hall; Keisaku Sato; Terry Lairmore; Marco Marzioni; Shannon Glaser; Fanyin Meng; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-24       Impact factor: 4.052

3.  Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.

Authors:  J Latorre; J M Moreno-Navarrete; J M Mercader; M Sabater; Ò Rovira; J Gironès; W Ricart; J M Fernández-Real; F J Ortega
Journal:  Int J Obes (Lond)       Date:  2017-01-25       Impact factor: 5.095

Review 4.  Advances of microRNAs in regulating mitochondrial function: new potential application in NAFLD treatment.

Authors:  Chuwei Yu; Jing Chen; Jin Ren
Journal:  Mol Biol Rep       Date:  2022-05-25       Impact factor: 2.742

Review 5.  Role of MicroRNAs in NAFLD/NASH.

Authors:  Gyongyi Szabo; Timea Csak
Journal:  Dig Dis Sci       Date:  2016-01-14       Impact factor: 3.199

Review 6.  MicroRNAs in Nonalcoholic Fatty Liver Disease.

Authors:  György Baffy
Journal:  J Clin Med       Date:  2015-12-04       Impact factor: 4.241

Review 7.  MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma.

Authors:  C Nelson Hayes; Kazuaki Chayama
Journal:  Int J Mol Sci       Date:  2016-02-24       Impact factor: 5.923

8.  MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.

Authors:  Alessandra Tessitore; Germana Cicciarelli; Filippo Del Vecchio; Agata Gaggiano; Daniela Verzella; Mariafausta Fischietti; Valentina Mastroiaco; Antonella Vetuschi; Roberta Sferra; Remo Barnabei; Daria Capece; Francesca Zazzeroni; Edoardo Alesse
Journal:  BMC Cancer       Date:  2016-01-05       Impact factor: 4.430

Review 9.  Function and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver Disease.

Authors:  Diego A Calvopina; Miranda A Coleman; Peter J Lewindon; Grant A Ramm
Journal:  Int J Mol Sci       Date:  2016-10-27       Impact factor: 5.923

10.  Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades.

Authors:  Zhichao Liu; Yuping Wang; Jürgen Borlak; Weida Tong
Journal:  Sci Rep       Date:  2016-04-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.